Your browser doesn't support javascript.
loading
Running on empty: Factors underpinning impaired cardiac output reserve in heart failure with preserved ejection fraction.
Sagmeister, Paula; Rosch, Sebastian; Fengler, Karl; Kresoja, Karl-Patrik; Gori, Tommaso; Thiele, Holger; Lurz, Philipp; Burkhoff, Daniel; Rommel, Karl-Philipp.
Afiliación
  • Sagmeister P; Department of Cardiology, Heart Center Leipzig at University of Leipzig and Leipzig Heart Science, Leipzig, Germany.
  • Rosch S; Department of Cardiology, University Hospital Mainz, Mainz, Germany.
  • Fengler K; Department of Cardiology, Heart Center Leipzig at University of Leipzig and Leipzig Heart Science, Leipzig, Germany.
  • Kresoja KP; Department of Cardiology, University Hospital Mainz, Mainz, Germany.
  • Gori T; Department of Cardiology, University Hospital Mainz, Mainz, Germany.
  • Thiele H; Department of Cardiology, Heart Center Leipzig at University of Leipzig and Leipzig Heart Science, Leipzig, Germany.
  • Lurz P; Department of Cardiology, University Hospital Mainz, Mainz, Germany.
  • Burkhoff D; Cardiovascular Research Foundation, New York, New York, USA.
  • Rommel KP; Department of Cardiology, Heart Center Leipzig at University of Leipzig and Leipzig Heart Science, Leipzig, Germany.
Exp Physiol ; 2024 Feb 29.
Article en En | MEDLINE | ID: mdl-38421268
ABSTRACT
Heart failure with preserved ejection fraction (HFpEF) is frequently attributed etiologically to an underlying left ventricular (LV) diastolic dysfunction, although its pathophysiology is far more complex and can exhibit significant variations among patients. This review endeavours to systematically unravel the pathophysiological heterogeneity by illustrating diverse mechanisms leading to an impaired cardiac output reserve, a central and prevalent haemodynamic abnormality in HFpEF patients. Drawing on previously published findings from our research group, we propose a pathophysiology-guided phenotyping based on the presence of (1) LV diastolic dysfunction, (2) LV systolic pathologies, (3) arterial stiffness, (4) atrial impairment, (5) right ventricular dysfunction, (6) tricuspid valve regurgitation, and (7) chronotopic incompetence. Tailored to each specific phenotype, we explore various potential treatment options such as antifibrotic medication, diuretics, renal denervation and more. Our conclusion underscores the pivotal role of cardiac output reserve as a key haemodynamic abnormality in HFpEF, emphasizing that by phenotyping patients according to its individual pathomechanisms, insights into personalized therapeutic approaches can be gleaned.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Exp Physiol Asunto de la revista: FISIOLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Exp Physiol Asunto de la revista: FISIOLOGIA Año: 2024 Tipo del documento: Article